ADAMA: Adjusted Profit Is Positive, but What Is Actually Non-Recurring?
The main article showed that ADAMA's margins recovered before pricing did. This follow-up shows that the move to a $5 million adjusted net profit rested on $145.4 million of adjustments, and only part of that gap looks truly non-recurring.
Where This Follow-Up Focuses
The main article argued that ADAMA's margins recovered before industry pricing did. This follow-up isolates the accounting question sitting inside that thesis: how does a company that still posted a reported net loss of $140.4 million in 2025 also present adjusted net income of $5.0 million, and how much of that gap can honestly be treated as non-recurring.
The first number to keep in view is straightforward. Total adjustments in 2025 came to $145.4 million. In other words, the entire move from reported net loss to a small adjusted profit depends on that bridge. The same pattern appears in the fourth quarter: a reported net loss of $64.3 million turned into adjusted net income of $5.8 million only after $70.2 million of adjustments. This is not a footnote. It is the core of the headline.
The easy mistake here is to choose one extreme. You can look only at the reported loss and dismiss the adjusted figure as noise, or you can look only at the adjusted profit and treat the reported loss as irrelevant. Both readings miss the point. Some adjustments do belong in the bucket of non-cash or non-operational items. A much larger part, though, is the real economic cost of Fight Forward, plant rationalization, remediation, and a debt structure that is still being reset. The right question is therefore not whether to adjust or not adjust. It is which items actually belong to ongoing earning power, and which items still show that the transition is unfinished.
On an analytical split, if you neutralize only the items that look closest to legacy accounting, transfer-asset amortization, acquisition-related PPA amortization, and the 2025 incentive-plans line, ADAMA still remains deep in loss territory, at roughly $110 million. The positive adjusted headline appears only after excluding restructuring, impairments, remediation and tax effects as well. That is the crux of the issue.
What Is Reasonable to Separate from Run-Rate Operations
There are adjustments where management's logic is understandable. The clearest example is the $21.9 million amortization of transfer assets linked to the 2017 ChemChina-Syngenta transaction. The note states explicitly that this amortization will continue until 2032 and remain meaningful until 2028. It is non-cash, and it says very little about ADAMA's 2025 pricing, volumes or plant-level execution. The same general logic applies to the $10.1 million of acquisition-related PPA amortization and other acquisition costs, most of which do not reflect 2025 operating performance.
| Item | 2025 | Why management excludes it | What still matters |
|---|---|---|---|
| Transfer-asset amortization from the 2017 transaction | $21.9 million | Non-cash cost from a historical transaction | The line does not disappear soon, and is expected to continue through 2032 |
| Acquisition-related PPA amortization and other acquisition costs | $10.1 million | Mostly accounting amortization of intangible assets | Reasonable to separate from operations, but not safe to assume it vanishes immediately |
| Other financing expenses | $9.5 million | One-time premium on the bond buyback | The same move also helped lower adjusted financing costs later on |
| Product-liability compensation | negative $25.2 million | Management removes a benefit, not only charges | This shows the bridge is not built only by adding costs back |
That last line matters. Product-liability compensation reduced the adjustments by $25.2 million. In other words, management is not only adding back charges to flatter the result. It is also stripping out a benefit that it does not treat as part of recurring earning power. That does not make the full bridge conservative, but it does prevent a lazy reading in which every adjustment is assumed to work in only one direction.
What Does Not Really Look Non-Recurring Yet
The bigger part of the bridge does not sit in legacy accounting at all. It sits in the cost of the transition itself. Restructuring and advisory costs reached $47.6 million in 2025, up from $36.4 million in 2024. Fixed assets and inventory impairment remained massive at $53.2 million, after $60.7 million the year before. Cleanup and remediation added another $14.3 million, after $18.4 million in 2024. These are not small one-off sparks at the edge of the story. They are three heavy lines that repeated for a second straight year.
The notes explain why it is hard to call these items non-recurring in the comfortable sense of the word. The restructuring line is explicitly tied to Fight Forward, which includes changes to organizational structure, workforce and managerial processes. The impairment note says the company chose to focus on higher-performing facilities, recorded impairments on lower-efficiency facilities, and then also impaired related inventory because some defective inventory could no longer be reprocessed. Cleanup and remediation costs were recorded in Israel in 2025, and in Israel and Brazil in 2024. Put differently, these are not random accounting smudges. They are the bill for the reset.
That is the important distinction between non-operational and irrelevant. Even if it eventually makes sense to exclude closure, advisory and remediation charges when thinking about the earnings power of the reshaped network, the 2025 filing still does not allow readers to pretend those costs are already behind the company. The report itself shows that they are still flowing through the bottom line in very material amounts.
Where the Improvement Does Look Real
None of this means the adjusted profit is empty. Quite the opposite. There is genuine operating improvement underneath the bridge. Adjusted gross profit rose 11% to $1.085 billion, and adjusted gross margin improved to 29.7% from 26.2%. Adjusted EBITDA rose 25% to $486 million, with margin improving to 13.3% from 10.4%. On the financing side, adjusted net financial expenses fell to $249 million from $279 million. The board report ties that mainly to the bond buyback executed late in Q2, lower hedging costs, and lower exposure to the Turkish lira.
That matters because this follow-up is not arguing that everything here is cosmetic. It is not. There is a real recovery in operating profitability, and there is a real improvement in the financing layer as well. But the reported loss says the company is not yet at the stage where it gets the benefit without still paying for the transition. The right way to read the $5 million adjusted net profit is as directional proof, not as a clean arrival point.
The bond buyback captures that duality well. On one side, it created $9.5 million of other financing expenses in 2025, a premium paid to repurchase debt. On the other side, that same move helped lower adjusted financing expenses. This is exactly the kind of item that can justify an adjustment in the year it is booked while also supporting a genuinely better forward financing profile.
So What Is Actually Non-Recurring Here
The most honest answer is that only part of the gap is truly non-recurring, while another part simply does not belong to steady-state earning power but also is not disappearing tomorrow morning.
The easiest bucket to separate is the legacy-accounting and clearly event-specific bucket, mainly transfer-asset amortization, PPA amortization, and the bond-buyback premium. Product-liability compensation also belongs in that event-driven category, which is why it makes sense that management removes it in both directions. By contrast, restructuring, impairments and remediation are not just accounting dirt. They are the price of building the more efficient network on which the recovery thesis depends.
That leaves the right read of 2025 somewhere between the two easy narratives. The correct conclusion is not "the accounts are messy, ignore them," and it is not "adjusted profit already proves the issue is solved." The correct conclusion is that the operating recovery is real, but the transition is still running through the reported P&L. For the gap between adjusted profit and reported loss to close in a convincing way, 2026 will have to show not only healthy margins, but also a much sharper drop in restructuring, impairment and remediation charges. Until then, the positive adjusted-profit headline is a credible starting point, but not yet full proof that the bottom line is clean.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.